↓ Skip to main content

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Overview of attention for article published in Lancet Oncology, September 2016
Altmetric Badge
71

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
6 news outlets
blogs
2 blogs
policy
1 policy source
twitter
21 X users
patent
6 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
1027 Dimensions

Readers on

mendeley
591 Mendeley